EXP
Experience Co Limited
🇦🇺 ASX
🏨 HOTELS, RESTAURANTS & LEISURE
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-8.92%
Annual Growth
5 years average annual growth
💰
2.70%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
4
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Experience Co. Ltd. is an adventure tourism company. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-03-27. The principal activities of the Company are the provision of adventure tourism and leisure experiences. The Company’s segments include Skydiving, Adventure Experiences, and Corporate. The Skydiving segment comprises tandem skydive and related products, with ancillary aircraft maintenance activities. The Adventure Experiences segment comprises tours to the Great Barrier Reef and Daintree region, high rope and zipline aerial activities, and nature-based walking and lodge-experiences. Its experiences include skydiving, island day trips, reef tours, rainforest tours, multi-day experiences and tree ropes and ziplining. Its island brands include Fitzroy Island Adventures, Big Cat Green Island Reef Cruises, and Calypso Low Isles. Its multi-day experiences include The Maria Island Walk, The Arkaba Walk, Arkaba Conservancy, and Bamurru Plains. Its reef tour brands include Dreamtime Dive & Snorkel, Reef Magic, and others.
📈 Performance
Price History
-49.02%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
2.70%
💰 Annual Dividend Earnings Per $1,000 invested**
$27.03
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of EXP, your last dividend payment(s) would have been:
$ 393.66
on Fri Sep 28 2018
$ 244.8
on Fri Sep 29 2017
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.01
Infinity%
2016
$0.01
Infinity%
2015
$0.01
100.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.13
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EXP
4
📊 Total Capital Earnings
$7K
🔃 Average investment frequency
89 weeks
💵 Average investment amount
$6,411
⏰ Last time a customer invested in EXP
367 days
EXP investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
75%
Less than 50k
25%
👶 Age of investors
18 - 25
26 - 34
25%
35 - 90
75%
🙋 Legal gender of investors
Female
25%
Male
75%
Pearlers who invest in EXP also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.62%
📊 Share price
$102.10 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
14.02%
📊 Share price
$140.20 AUD
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
🌏 GLOBAL
🤖 TECHNOLOGY
IVV
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
20.56%
📊 Share price
$63.57 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.
🙌 Performance (5Yr p.a)
-0.04%
📊 Share price
$278.11 AUD
🧬 BIOTECHNOLOGY
🕊️ SOCIALLY AWARE
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
🙌 Performance (5Yr p.a)
15.45%
📊 Share price
$101.94 AUD
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
🌏 GLOBAL
📈 HIGH PRICE GROWTH
Want more shares? Try these...
Elixir Energy Ltd. engages in the exploration of oil and gas. The company is headquartered in Adelaide, South Australia. The company went IPO on 2004-07-19. The firm is focused on primarily focused on an exploration and appraisal program targeting natural gas in the form of coal-bed methane (CBM) in Queensland, Australia and the South Gobi, Mongolia. The company is also developing Gobi H2 green hydrogen project and solar project in Mongolia. The firm holds 100% of a Queensland exploration permit ATP 2044, named Grandis Gas Project, located in the Taroom Trough of the Bowen Basin, Queensland. Its Grandis Gas Project covers an area of 1,000 square kilometers (km2) located close to existing gas transmission infrastructure centered on the Wallumbilla gas hub. he Nomgon IX CBM PSC (Nomgon Project) is located on the Mongolian Chinese border, around 400 kilometers (km) North of China’s main gas transmission grid. The Nomgon Project license area covers 30,000 km2 (seven million acres). Its subsidiaries include Golden Horde Pty Ltd, GOH LLC, GOH Clean Energy LLC.
🙌 Performance (5Yr p.a)
5.14%
📊 Share price
$0.04 AUD
⚡️ ENERGY
EXL
Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-08. The firm is engaged in marketing and selling hemp derived and other plant-based nutraceuticals, skincare and food products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of complementary products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp Foods Australia, Mt Elephant and Field Day and are sold through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products based in Colorado, United States. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.
🙌 Performance (5Yr p.a)
-18.20%
📊 Share price
$0.04 AUD
🛍️ CONSUMER
